150 related articles for article (PubMed ID: 14522944)
1. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.
Sitcheran R; Cogswell PC; Baldwin AS
Genes Dev; 2003 Oct; 17(19):2368-73. PubMed ID: 14522944
[TBL] [Abstract][Full Text] [Related]
2. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
Tubaro C; Arcuri C; Giambanco I; Donato R
J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS
Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425
[TBL] [Abstract][Full Text] [Related]
5. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.
Fernández-Lloris R; Viñals F; López-Rovira T; Harley V; Bartrons R; Rosa JL; Ventura F
Mol Endocrinol; 2003 Jul; 17(7):1332-43. PubMed ID: 12677004
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.
Akiyama H; Chaboissier MC; Martin JF; Schedl A; de Crombrugghe B
Genes Dev; 2002 Nov; 16(21):2813-28. PubMed ID: 12414734
[TBL] [Abstract][Full Text] [Related]
7. ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-κB signaling activity.
Liu XH; Bauman WA; Cardozo C
Biochem Biophys Res Commun; 2015 Aug; 464(1):208-13. PubMed ID: 26102030
[TBL] [Abstract][Full Text] [Related]
8. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
Locker M; Kellermann O; Boucquey M; Khun H; Huerre M; Poliard A
J Bone Miner Res; 2004 Jan; 19(1):100-10. PubMed ID: 14753742
[TBL] [Abstract][Full Text] [Related]
9. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability.
Kinkel MD; Horton WE
J Cell Biochem; 2003 Apr; 88(5):941-53. PubMed ID: 12616533
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9.
Robins JC; Akeno N; Mukherjee A; Dalal RR; Aronow BJ; Koopman P; Clemens TL
Bone; 2005 Sep; 37(3):313-22. PubMed ID: 16023419
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha.
Murakami S; Lefebvre V; de Crombrugghe B
J Biol Chem; 2000 Feb; 275(5):3687-92. PubMed ID: 10652367
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
13. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation.
Song JJ; Aswad R; Kanaan RA; Rico MC; Owen TA; Barbe MF; Safadi FF; Popoff SN
J Cell Physiol; 2007 Feb; 210(2):398-410. PubMed ID: 17111364
[TBL] [Abstract][Full Text] [Related]
15. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
Hill TP; Später D; Taketo MM; Birchmeier W; Hartmann C
Dev Cell; 2005 May; 8(5):727-38. PubMed ID: 15866163
[TBL] [Abstract][Full Text] [Related]
16. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.
Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E
Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells.
Ushita M; Saito T; Ikeda T; Yano F; Higashikawa A; Ogata N; Chung U; Nakamura K; Kawaguchi H
Osteoarthritis Cartilage; 2009 Aug; 17(8):1065-75. PubMed ID: 19254740
[TBL] [Abstract][Full Text] [Related]
18. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner.
Yano F; Kugimiya F; Ohba S; Ikeda T; Chikuda H; Ogasawara T; Ogata N; Takato T; Nakamura K; Kawaguchi H; Chung UI
Biochem Biophys Res Commun; 2005 Aug; 333(4):1300-8. PubMed ID: 15979579
[TBL] [Abstract][Full Text] [Related]
19. Expression of transcription factor Sox9 in rat L6 myoblastic cells.
Matsushita T; Matsui N; Fujioka H; Kubo S; Kuroda R; Kurosaka M; Yoshiya S
Connect Tissue Res; 2004; 45(3):164-73. PubMed ID: 15512770
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.
Di Marco S; Mazroui R; Dallaire P; Chittur S; Tenenbaum SA; Radzioch D; Marette A; Gallouzi IE
Mol Cell Biol; 2005 Aug; 25(15):6533-45. PubMed ID: 16024790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
